These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

307 related articles for article (PubMed ID: 23047787)

  • 1. The Drug Safety and Risk Management Advisory Committee: a case study of meeting frequency, content, and outcomes before and after FDAAA.
    Morrato EH; Ling SB
    Med Care; 2012 Nov; 50(11):970-86. PubMed ID: 23047787
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association of Advisory Committee Votes With US Food and Drug Administration Decision-Making on Prescription Drugs, 2010-2021.
    Daval CJR; Teng TW; Russo M; Kesselheim AS
    JAMA Health Forum; 2023 Jul; 4(7):e231718. PubMed ID: 37418270
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association Between Food and Drug Administration Advisory Committee Recommendations and Agency Actions, 2008-2015.
    Zhang AD; Schwartz JL; Ross JS
    Milbank Q; 2019 Sep; 97(3):796-819. PubMed ID: 31304643
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Re: Joint meeting for Bone, Reproductive and Urologic Drugs Advisory Committee (BRUDAC) and the Drug Safety and Risk Management Advisory Committee (DSARM AC), September 17, 2014.
    Seftel AD
    J Urol; 2015 Feb; 193(2):623-5. PubMed ID: 25617291
    [No Abstract]   [Full Text] [Related]  

  • 5. Oncologic Drugs Advisory Committee Recommendations and Approval of Cancer Drugs by the US Food and Drug Administration.
    Tibau A; Ocana A; Anguera G; Seruga B; Templeton AJ; Barnadas A; Amir E
    JAMA Oncol; 2016 Jun; 2(6):744-50. PubMed ID: 26940233
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Does seating location impact voting behavior on Food and Drug Administration advisory committees?
    Broniatowski DA; Magee CL
    Am J Ther; 2013; 20(5):502-6. PubMed ID: 21642834
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Financial conflict of interest disclosure and voting patterns at Food and Drug Administration Drug Advisory Committee meetings.
    Lurie P; Almeida CM; Stine N; Stine AR; Wolfe SM
    JAMA; 2006 Apr; 295(16):1921-8. PubMed ID: 16639051
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Food and Drug Administration advisory committees and panels: how they are applied to the drug regulatory process.
    Ciociola AA; Karlstadt RG; Pambianco DJ; Woods KL; Ehrenpreis ED;
    Am J Gastroenterol; 2014 Oct; 109(10):1508-12. PubMed ID: 25001252
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The decision-making process of US Food and Drug Administration advisory committees on switches from prescription to over-the-counter status: a comparative case study.
    Nguyen NT; Cook DM; Bero LA
    Clin Ther; 2006 Aug; 28(8):1231-1243. PubMed ID: 16982301
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Advisory committee; Risk Communication Advisory Committee; establishment. Final Rule.
    Food and Drug Administration, HHS
    Fed Regist; 2007 Jul; 72(144):41221-2. PubMed ID: 17674496
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Revisiting financial conflicts of interest in FDA advisory committees.
    Pham-Kanter G
    Milbank Q; 2014 Sep; 92(3):446-70. PubMed ID: 25199895
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Risk management policy and black-box warnings: a qualitative analysis of US FDA proceedings.
    Cook DM; Gurugubelli RK; Bero LA
    Drug Saf; 2009; 32(11):1057-66. PubMed ID: 19810777
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Financial Conflicts of Interest at FDA Drug Advisory Committee Meetings.
    Hayes MJ; Prasad V
    Hastings Cent Rep; 2018 Mar; 48(2):10-13. PubMed ID: 29590518
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Advisory committee; Pediatric Advisory Committee; establishment. Final Rule.
    Food and Drug Administration, HHS
    Fed Regist; 2004 Aug; 69(147):46098-9. PubMed ID: 15287133
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Has the FDA Amendments Act of 2007 impaired drug development?
    Franson TR
    Clin Pharmacol Ther; 2011 Feb; 89(2):169-71. PubMed ID: 21252933
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Product Approvability Recommendations From FDA Advisory Committees:: Inconsistently Sought, Indirectly Obtained.
    Gulfo JV; Briggeman J; Gamie A
    Ther Innov Regul Sci; 2018 Nov; 52(6):784-792. PubMed ID: 29714584
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Advisory committees; OTC Drugs Advisory Committee; establishment--FDA. Final rule.
    Fed Regist; 1991 Sep; 56(185):48103-4. PubMed ID: 10114368
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characteristics and conflicts of interests of public speakers at the Psychopharmacologic Drug and Advisory Committee meetings regarding psychiatric drugs.
    Roberts W; Jellison S; Wayant C; Vassar M
    BMJ Evid Based Med; 2020 Aug; 25(4):145-146. PubMed ID: 32019896
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The FDA Acetaminophen Advisory Committee Meeting - what is the future of acetaminophen in the United States? The perspective of a committee member.
    Krenzelok EP
    Clin Toxicol (Phila); 2009 Sep; 47(8):784-9. PubMed ID: 19735211
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A Retrospective Review of Center for Biologics Evaluation and Research Advisory Committee Meetings in the Context of the FDA's Benefit-Risk Framework.
    Mutanga JN; Nukala U; Rodriguez Messan M; Yogurtcu ON; McCormick Q; Sauna ZE; Whitaker BI; Forshee RA; Yang H
    AAPS J; 2023 Feb; 25(1):24. PubMed ID: 36759415
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.